330 related articles for article (PubMed ID: 7955256)
1. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
2. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
3. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
[TBL] [Abstract][Full Text] [Related]
4. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
5. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
[TBL] [Abstract][Full Text] [Related]
6. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
8. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.
Kopf GS; Hammond GL; Geha AS; Elefteriades J; Hashim SW
Circulation; 1987 Sep; 76(3 Pt 2):III132-6. PubMed ID: 3621536
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
10. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
11. Combined mitral and aortic valve replacement for rheumatic heart disease: fifteen-year follow up and long-term results.
Panda BR; Shankar R; Kuruvilla KT; Philip MA; Thankachen R; Shukla V; Korula RJ
J Heart Valve Dis; 2009 Mar; 18(2):170-9. PubMed ID: 19455892
[TBL] [Abstract][Full Text] [Related]
12. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
13. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
[TBL] [Abstract][Full Text] [Related]
14. Four- to seven-year follow-up of patients undergoing Carpentier-Edwards porcine heart valve replacement.
Gallo I; Artiñano E; Nistal F
Thorac Cardiovasc Surg; 1985 Dec; 33(6):347-51. PubMed ID: 2417370
[TBL] [Abstract][Full Text] [Related]
15. Twenty-year comparison of tissue and mechanical valve replacement.
Khan SS; Trento A; DeRobertis M; Kass RM; Sandhu M; Czer LS; Blanche C; Raissi S; Fontana GP; Cheng W; Chaux A; Matloff JM
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):257-69. PubMed ID: 11479498
[TBL] [Abstract][Full Text] [Related]
16. Risk-benefit analysis of warfarin therapy in Hancock mitral valve replacement.
Hill JD; LaFollette L; Szarnicki RJ; Avery GJ; Wilson RM; Gerbode F; Kerth WJ; Rodvien R
J Thorac Cardiovasc Surg; 1982 May; 83(5):718-23. PubMed ID: 6978975
[TBL] [Abstract][Full Text] [Related]
17. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
18. Prognosis after aortic valve replacement with the Carpentier-Edwards pericardial valve: use of microsimulation.
Puvimanasinghe JP; Takkenberg JJ; Eijkemans MJ; Steyerberg EW; van Herwerden LA; Grunkemeier GL; Habbema JD; Bogers AJ
Ann Thorac Surg; 2005 Sep; 80(3):825-31. PubMed ID: 16122436
[TBL] [Abstract][Full Text] [Related]
19. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: mid-term clinical results.
Meyns B; Szecsi J; Flameng W; Daenen W
J Heart Valve Dis; 1994 Jan; 3(1):66-70. PubMed ID: 8162219
[TBL] [Abstract][Full Text] [Related]
20. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
